Diagnostic antibodies and antigens for Tumor and Cancer testing: CA-125, SCC Ag, PIVKA-¢ò, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, CYFRA21-1, HER2, FER, HSP90¦Á, S100B

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several markers such as hyroglobulin (TG), cancer antigen 125 (CA-125), squamous cell carcinoma antigen (SCC Ag), Protein induced by vitamin K absence-II (PIVKA-II), Gastrin-releasing peptide (Pro-GRP), Calcitonin, Neuron specific enolase (NSE), Cancer Antigen 72-4 (CA-724), Human epididymis protein 4 (HE4), Cancer antigen 15-3 (CA15-3), cytokeratin-19 (CYFRA21-1), human epidermal growth factor receptor 2 (HER2), Ferritin (FER), Heat shock proteins 90-alpha (HSP90α), S100 proteins (S100B) and so on have been identified to be associated with the specific cancer. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Genemedi supplies antibodies and antigens for Tumor and Cancer testing for a wide selection of choices (please see below).